版本:
中国

BRIEF-Trovagene enters into agreement with Astrazeneca to utilize Trovera CTDNA test and services in prospective biomarker study

June 12 Trovagene Inc

* Trovagene enters into agreement with astrazeneca to utilize trovera® ctdna test and services in prospective biomarker study

* Trovagene Inc - has entered into an agreement with astrazeneca to provide trovera® urine ctdna biomarker test and services

* Trovagene Inc - trovera egfr urine liquid biopsy test will initially be used in an open label prospective biomarker study Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐